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ABSTRACT We apply a theoretical aggregation model to laboratory and epidemiological prion disease incubation time data.
In our model, slow growth of misfolded protein aggregates from small initial seeds controls the latent or lag phase; aggregate
ﬁssioning and subsequent spreading leads to an exponential growth phase. Our model accounts for the striking reproducibility
of incubation times for high dose inoculation of lab animals. In particular, low dose yields broad incubation time distributions,
and increasing dose narrows distributions and yields sharply deﬁned onset times. We also explore how incubation time
statistics depend upon aggregate morphology. We apply our model to ﬁt the experimental dose-incubation curves for distinct
strains of scrapie, and explain logarithmic variation at high dose and deviations from logarithmic behavior at low dose. We use
this to make testable predictions for infectivity time-course experiments.
INTRODUCTION
Understanding the factors which regulate the incubation
times for infectious prion diseases is important for assessing
the risk of illness after potential exposure as well as for
developing treatments which can delay disease onset. There
are several striking aspects to prion disease incubation,
which are not well-understood.
The incubation times can run into years and decades
(Prusiner et al., 1982), and yet, at the laboratory scale have
been found to be highly reproducible. In fact, the re-
producibility of incubation times with dose has been used as
an independent measure of infectivity titer (Prusiner et al.,
1982, 1999).
There seem to be distinct stages for the disease
incubation after intracerebral inoculation: after rapid initial
clearance, there is a lag phase (also termed zero phase;
see Dickinson and Outram, 1979; Kimberlin and Walker,
1988) during which there is little or no infectivity, and an
exponential growth or doubling phase, during which the
infectivity increases exponentially with a well-deﬁned
doubling period (Manuelidis and Fritch, 1996; Bolton,
1998; Beekes et al., 1996). Understanding the lag phase is
clearly important as any treatment strategy is more likely
to succeed before the exponential growth phase takes
over.
As the dose of infection is increased in the laboratory, the
incubation times become sharply deﬁned and saturate to
a dose-independent value. Below this saturation dose, the
incubation time shows a logarithmic dose dependence and at
low dose the distribution becomes broad and deviations from
logarithmic behavior are observed (Mclean and Bostock,
2000). Such a broad distribution has also been found in
epidemiological studies of bovine spongiform encephalop-
athy (BSE) in England (Stekel et al., 1996; Anderson et al.,
1996).
For infection across species, there is a species barrier,
and the ﬁrst passage takes considerably longer to incubate
than subsequent passages (Kimberlin and Walker, 1977,
1978).
While prion aggregation has been observed in vitro, the
aggregates are neurotoxic but not infectious (Post et al.,
2000). These are the issues which motivate our study.
The purpose of this article is to test the extent to which
a purely physicochemical model can capture the main
reproducible features of prion disease incubation. In par-
ticular, we emphasize the importance of the aggregate mor-
phology in determining the statistics of incubation times. Our
basic hypothesis is that the lag phase is determined by
growth of misfolded protein aggregates from initial small
seeds (acquired through infection) to a typical ﬁssioning
dimension, whereas subsequent aggregate ﬁssioning and
spreading leads to exponential growth and the doubling
phase. For a single seed, the lag phase develops a broad
but well-deﬁned distribution, which we can calculate via
a microscopic statistical model. Thus, when the infection is
very dilute, there is a broad distribution of incubation times.
At higher doses of infection, self-averaging due to in-
dependent growth from many seeds leads to sharply deﬁned
incubation times. The dose dependence and its saturation, as
well as the ratio of lag time to doubling time depends on the
morphology of the aggregates, i.e., whether one has linear
ﬁbrils or compact higher-dimensional aggregates. In this
sense, details of incubation time distributions provide an
indirect means to infer early growth morphologies. Alterna-
tive theoretical models which deal with the above issues have
also been developed in the literature (Eigen, 1996; Nowak
et al., 1998; Masel et al, 1999, Masel and Jansen, 2000;
Stumpf and Krakauer, 2000; Payne and Krakauer, 1998;
Kellershoh and Laurent, 2001).
The extent to which such a model explains the
experimental phenomenology would help address the
following questions:
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Are the incubation times dominated by the nucleation and
growth of misfolded protein aggregates?
Are the two phases of prion disease incubation, the lag
phase and the exponential growth phase, controlled
by the same process, i.e., aggregation of misfolded
proteins?
Assuming that aggregate growth controls the incubation
timescales, we are led to ask, what is the aggregate
morphology during early growth and how does it in-
ﬂuence the dose-incubation curves?
Does current data inform us about the characteristic size
of the aggregates?
Employing statistical simulations of prion aggregation
(based upon cellular automata rules) we argue here that
several features of prion disease can be explained by ex-
ploring the statistics of the two phases of the disease in-
cubation. Within our model, we show that compact
two-dimensional aggregates can provide the observed broad
distribution of incubation times for dilute doses and at the
same time account for the typical large difference between
lag time and doubling time. We present analytic calculations
which provide a functional form for the distribution that can
be used in further epidemiological studies, and we use these
results to infer the dose dependence of the incubation time.
Furthermore, our analysis shows how the dose-incubation
curve can be related to experimental measurements of the
time course of infectivity and in particular, testable pre-
dictions can be made using our model for the dose de-
pendence of the lag phase. Finally, we apply our model to
epidemiological data for BSE (mad cow disease), from
which we conclude that within the model the incubation time
is dominated by slow aggregation from a few small (tens of
nm scale) starting seeds. This size scale of these seeds is
comparable in small animals, but the estimated attachment
rates are slower by an order of magnitude or more.
We organize our article as follows: A Model Distribution
and Dose-Incubation Curves discusses a model incubation
time distribution, which illustrates how our basic picture
relates to dose-incubation curves in prion diseases. The
sections Cellular Automata Simulations, Stochastic Analysis
of Aggregation, and Aggregate Fissioning deal with mi-
croscopic models related to protein misfolding, aggregation,
and ﬁssioning. In the sections Dose-Incubation Curve,
Connection to Epidemiological Data, and Discussion, we
come back to the dose-incubation curves, connections to
epidemiological data, and the disease phenomenology, and
discuss them in the context of our models and present our
conclusions.
A MODEL DISTRIBUTION AND
DOSE-INCUBATION CURVES
We ﬁrst illustrate the bare bones of our proposed picture
for prion disease incubation by using a model distribution,
where calculations can be done analytically. As mentioned in
the previous section, our assumption is that the lag phase
corresponds to aggregation of misfolded prions from the
initial seed up to a ﬁssioning size. This is a stochastic pro-
cess and, correspondingly, there will be a distribution of
aggregation times. Subsequent to this aggregation, we
assume (based upon experimental observations) that the
number of seeds increases exponentially with a well-deﬁned
doubling time (t2). This exponential growth continues until
the number of seeds reaches a critical value which signals the
onset of clinical symptoms and the end of the incubation
period. We note that this critical value depends on the
particular strain of prion disease, inasmuch as different
strains target different areas of the brain and can corre-
spondingly cause differing amounts of damage in the target
tissue.
In this section, to illustrate the key ideas, we consider an
oversimpliﬁed (but analytically soluble) model of the
aggregation time distribution P(t) associated with a single
seed which is uniform on the interval t0 # t # t0 1 T:
PðtÞ ¼ 0 t\t0 (1)
¼ 1
T
t0\t\t01 T (2)
¼ 0 t[t01 T: (3)
It is useful for what follows to set T ¼ n1t2, which
measures T in units of the doubling time.
Our simple model assumes that when there are many seeds
present, each initial seed will start ﬁssioning into two new
seeds after an aggregation time sampled from the above
distribution. We will assume that once a seed has ﬁssioned
once, it continues to ﬁssion or effectively double in a time t2,
which is independent of the above distribution. The micro-
scopic basis for this assumption will be explained in
Aggregate Fissioning. The incubation time is given by the
mean time taken for a given initial number of seeds (Di) to
reach a critical number (Df) which is characteristic of when
clinical symptoms arise for a given strain.
The dose dependence of the incubation time is then
calculated through the following steps:
1. First, we calculate the mean ﬁrst-arrival time, i.e., the
mean time taken for the ﬁrst aggregate ﬁssioning event.
Let the cumulative probability for the ﬁrst-arrival time for
Di seeds be given by F
ðDiÞðtÞ: Since each seed grows
independently, this can be related to the cumulative
probability for the ﬁrst-arrival time for a single seed via
the relation
FðDiÞðtÞ ¼ 1 ð1 Fð1ÞðtÞÞDi : (4)
The mean ﬁrst-arrival time t1 is given by solving
FðDiÞðt1Þ ¼ 1=2: For the simple probability distribution
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discussed above, the mean ﬁrst-arrival time is well-
approximated by the expression
t1ðDiÞ ¼ t01 n1
2Di
t2: (5)
Note that, for a single seed, t1 ¼ t0 1 n1t2/2 is the mean
of the distribution P(t), whereas as Di becomes large, t1
tends to t0, i.e., seeds begin to arrive at the onset of the
distribution.
2. We now proceed to calculate the time spent in the
doubling phase, i.e., the time taken until the number of
seeds reaches Df. All the aggregates formed after
ﬁssioning are assumed to further ﬁssion in time t2.
Besides these, initial seeds continue to arrive, i.e.,
aggregate to the ﬁssioning size and thus join the number
of seeds that are doubling. The number of initial seeds
that arrive during one doubling time interval t2 is given
by intðDi=n1Þ; where int(x) refers to the integer part of x.
Let n2 be the number of doubling steps needed for the
number of seeds to reach the ﬁnal number Df. The
number of seeds generated after n2 doubling steps is
approximately given by 2n2ð11intðDi=n1ÞÞ: Thus the
number of doubling steps n2 is given by
n2 ¼ log2ðDfÞ  log2 11 int
Di
n1
  
: (6)
3. The mean incubation time, which is the sum of the lag-
phase time and the doubling phase time, is now given by
ti ¼ t1ðDiÞ1 n2t2 ¼ t01 n1
2Di
t2
1 log2ðDfÞ  log2 11 int
Di
n1
   
t2: (7)
The above equation gives the dose dependence of the
incubation time for the model distribution. It should be
noted that this expression already explains several
generic features seen in experimental dose-incubation
curves (DICs) and in the microscopic models we present
in later sections. These are logarithmic dose dependence
at high doses and deviations from logarithmic behavior at
low doses. From the above expression for the incubation
time, it can be seen that the dominant contribution to the
incubation time at high Di comes from the doubling
phase which gives a logarithmic dose dependence.
However at low doses (D # n1), the time spent in the
doubling phase does not change appreciably with dose.
Instead, the variation in the incubation time comes from
the dose dependence of the ﬁrst-arrival time, i.e., the lag-
phase time. This is reﬂected as a deviation from the
logarithmic behavior in the DIC which is seen in
experimental DICs (Prusiner et al., 1980). Our model
thus makes the testable prediction that deviations from
logarithmic behavior in the DIC should correspond to
increases in the lag phase.
We now proceed to develop microscopic models for the
initial aggregation process. The next section discusses the
cellular automata approach to this problem.
CELLULAR AUTOMATA SIMULATIONS
Theoretical modeling of incubation times (Nowak et al.,
1998; Eigen, 1996; Harper and Lansbury, 1997) starting at
the molecular level is all but impossible with a 20 order-of-
magnitude span between molecular motion timescales and
those of disease onset. On the other hand, kinetic theory
allows one to model long-time processes but ignores short
distance spatial ﬂuctuations, important in nucleation and
growth. We have developed a lattice-based, protein-level
cellular-automata approach, which bridges these two meth-
odologies (Slepoy et al., 2001). Previously, we used it to
calculate aggregation-time distributions, which compared
favorably with the incubation times inferred from BSE data
(Stekel et al., 1996; Anderson et al., 1996). We also showed
that playing with the rules in such simple models can be
a cheap way to suggest, constrain, and guide treatment
protocols.
Our models consist of dilute concentrations of proteins
diffusing on the lattice and interconverting between their
properly folded state (PrPc) and the misfolded state (PrPSc)
(Cohen and Prusiner, 1998) with certain stochastic rules.
Even though we employ very simple rules for the in-
terconversion, from our basic understanding of statistical
mechanics, we expect the long-time behavior to be modeled
correctly. The motivation for our rules is the role of
surrounding water molecules in determining the protein
conformation. We assume that a monomer isolated from
others (surrounded by water molecules) stays in its properly
folded state. However, when proteins are surrounded by
other proteins, thus excluding water from parts of their
neighborhood, they can change conformations and go into
a misfolded state (involving b-sheet bonding). A key
parameter of our model is the coordination, qc, at which
the misfolded conformation PrPSc becomes stable. Only
misfolded monomers may remain stably in a cluster, possibly
breaking away from a cluster when they fold back into the
PrPc form. Note that our model does not discount the
inﬂuence of other factors in driving the transition from PrPc
to PrpSc. Our aim is to understand how the aggregation
process changes with qc, which we proceed to do in the
following.
Assuming aggregation happens on the cell surface, we
choose a two-dimensional hexagonal lattice. The lattice
structure and the detailed protein motion are not crucial in
our model. At each time step, proteins can move randomly
by at most a unit lattice spacing. The magnitude of the time
step is set by the time for a single monomer to misfold. It is
implicitly assumed that proteins coadsorb with each other
followed either by a conversion in shape or separation. It is
this conversion process that sets the unit of time.
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By playing with the cellular automata rules it is possible to
get different aggregate morphologies and aggregation time
distributions. First, we consider the case where proteins are
isotropic objects. We have performed a large number of runs
at values of qc ¼ 1, 2, and 3, with different monomer
concentrations (held ﬁxed during the simulation). The
aggregation time is deﬁned as the time required to grow
from initial seed of size Ai to a ﬁnal size A. We always
choose the initial seed size to be the minimally stable
oligomer of misfolded proteins for a given coordination rule;
for qc ¼ 1,2,3, then Ai ¼ 2,3,10. Note that for qc ¼ 3, the Ai
¼ 7 seed is also stable, but possesses a likely spurious trimer-
limited attachment barrier to pass to size aggregate sizeAi¼
10. For a very wide range of concentrations, the lower co-
ordination rules effectively remove the nucleation barrier,
leading to frequent nucleation of new clusters. Typical ag-
gregate conﬁgurations (and stable seeds) are shown in Fig. 1.
From these studies, we see that lowering the critical
coordination provides too rapid a growth for prion ag-
gregates over a wide concentration region, and with no nu-
cleation barrier at these concentrations. In contrast, for qc ¼
3, the aggregation is very slow and it is characterized by
a broad incubation time distribution, with a clear separation
in timescales for seeded and unseeded (i.e., infectious and
sporadic) cases.
We can also obtain one-dimensional ﬁbril growth by
considering the proteins to be anisotropic. For example, on
a square lattice, we can get ﬁbrils by: i), identifying
a preferred bonding face to our simple point proteins, now
made into squares. ii), We choose a critical coordination of
2. iii), We make edge bonding of proteins with adjacent
preferred faces to be quite strong under coordination q ¼ 1
(i.e., the conversion probability is [50%), and somewhat
less strong for face-to-face meeting of proteins. We assume
zero conversion probabilities for all other faces. By
choosing three kinds of faces with appropriate rules, we
can obtain equivalent results on the hexagonal lattice. These
rules assure ﬁbril growth which is dimer dominated (see
Fig. 1).
STOCHASTIC ANALYSIS OF AGGREGATION
In the low concentration limit, the aggregation results from
a sequential addition of proteins to the initial seed. However,
addition of monomers is not always stable. Given the rules,
various stages of the aggregate size and shape require a pair
of proteins (a dimer) to arrive simultaneously, to attach in
a stable manner. Thus, the entire process can be approxi-
mated by one of stochastic sequential addition of monomer
and dimer units. As the concentration, c, goes to zero, the
monomer addition rate is proportional to c, whereas the
dimer addition rate is proportional to c2, and thus the growth
will involve a minimum number of dimers and these will
provide the dominant contribution to the growth times.
The growth to a ﬁnal size A from an initial size Ai
involves sequential addition of n units. The probability for
the successive additions at intervals t1, t2, . . . , tn is
Pðt1; t2; . . . ; tnÞ ¼
Yn
j¼1
pje
pjtj ; (8)
where the rate for the jth unit, pj, depends on the geometry of
the aggregate and the kind of unit (monomer or dimer) to be
added. Hence, the probability distribution associated with the
total growth time is
PðtÞ ¼
ð‘
0
dt1 . . .
ð‘
0
dtn
Yn
j¼1
pje
pjtd t  +
n
i¼1
ti
 
: (9)
This integral can be evaluated by standard methods for
arbitrary pi. We note the answers for two cases:
FIGURE 1 Morphologies of seeds (bold Bs) and corre-
sponding aggregates due to the different rules: (A) qc ¼ 3,
(B) qc ¼ 2, (C) qc ¼ 1, and (D) ﬁbril growth (see text).
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1. The attachment probabilities are identical for each unit,
i.e., pj ¼ p for all j. In this case the probability
distribution is the g-distribution,
PðtÞ ¼ pðptÞ
n1
ðn 1Þ! e
pt
: (10)
2. The rate, pj ¼ p 1 jp9, increases linearly with j. In this
case we obtain the b-distribution in et (Szabo, 1988),
PðtÞ ¼ Aeðp1p9Þtð1 ep9tÞn1: (11)
In one-dimensional ﬁbril growth, dimers are attached
one by one with the area available for attachment of
dimers staying constant, and thus Eq. 10 applies. For two-
dimensional compact growth, slow dimer attachments have
to be combined with rapid ﬁlling up of rows by mono-
mers. In the low concentration limit, the rate is limited by
dimer attachment probabilities which increase linearly with
the number of dimers already attached, thus leading to
Eq. 11.
At ﬁnite concentrations, the monomer attachment times
can no longer be neglected, and a more accurate treatment of
the timescales in the two-dimensional case requires a convo-
lution of probabilities for monomer attachment times with
those for dimer attachment times. The geometrical counting
of number of monomers and number of dimers needed
to grow to the desired size is straightforward. For the
monomers, the distribution of net attachment time is given
by the Gamma distribution, i.e., Eq. 10 above, whereas for
the dimers it is given by Eq. 11. Since the dimer and
monomer attachment times can be taken as independent
random variables, the distribution of the total attachment
time is given by a convolution of the monomer and dimer
probability distributions. The functional form thus obtained
can be used to develop accurate ﬁts to the numerical data, as
shown in Fig. 2 A.
An important aspect of our two-dimensional model is the
asymptotic compression of the distributions at low concen-
trations. The initial stage of the growth is extremely slow and
the process speeds up signiﬁcantly as the aggregate grows.
Thus, the mean aggregation time, tm, to go from an initial
seed Ai to a ﬁnal size A, can be much larger than the typical
aggregate-doubling time, t2, to go from size A/2 to A. Fig. 3
shows the ratio t2/tm for different concentrations and
different ﬁnal sizesA. The crossover to monomer-dominated
behavior ðt2=tm  1=2Þ is indicated at the highest concen-
tration, whereas at low concentrations this ratio can be much
smaller.
AGGREGATE FISSIONING
Fissioning of aggregates leads to exponential growth as the
ﬁssion products provide seeds for the next round of
aggregation. In this subsection, we consider two mechanistic
models of the ﬁssion process associated with either pro-
teolytic cleavage of aggregates or mechanically induced
breakage. We acknowledge that other models are possible
(such as continuous ﬁssioning from the aggregate or multiple
FIGURE 2 (A) Comparison of simulation
data for single seed aggregation (Ai ¼ 10,
A ¼ 80, and c ¼ 0.2%) and ﬁt using analytical
calculations (see text) for two-dimensional
growth with qc ¼ 3. The unit of time is 1
simulation sweep. (B) Probability distributions
for (a) qc ¼ 1, (b) qc ¼ 2, (c) qc ¼ 3, and (d)
sporadic (i.e., with no initial seed) with qc ¼ 3
at the same concentration (c ¼ 0.2%). The
maximum probability for all distributions is
scaled to unity. The sporadic result is obtained
by scaling the data at c ¼ 1% with an
empirically determined c3 factor.
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seed ﬁssioning), and we shall discuss these brieﬂy at the end
of the section.
We assume that the time required to ﬁssion an aggregate
(i.e., to actually split it up) is small compared to the
aggregation time. This implies a narrow distribution of
ﬁssion sizes peaked, say, at aggregate size A, and in this
limit our results are expected to be independent of the width
of the ﬁssion distribution.
We consider two extreme limiting models of ﬁssion:
Mechanical. In this case, once the aggregate reaches
ﬁssion size A, it splits into two fragments of equal size A/2.
This should approximately describe the situation in which
aggregate size is limited by nerve cell curvature, for example
(i.e., aggregation favors ﬂat planar or linear structures, but
the curvature of the neuron tends to favor curved structures).
Physiological. In this case, the aggregate can break into all
smaller lengths at the ﬁssion scale. This mimics the outcome
of protease attack for which there is no obvious preferred site
for breakage.
We take a ﬁxed background concentration of monomers,
which should be reasonable for at least short times in the
infection time course. The kinetic equation for the time
evolution of aggregates with size n (measuring the number of
dimers present) and concentration [an] is, for n\A,
d½an
dt
¼ pn1½an1  pn½an1 pf;n½aA; (12)
and, for n ¼ A,
d½aA
dt
¼ pA1½aA1  pf0½aA: (13)
Here, for one-dimensional aggregation pn ¼ p0, whereas
for the two-dimensional aggregation speciﬁed by our three
critical coordination rules discussed in Cellular Automata
Simulations, pn ¼ p 1 np9. For mechanical ﬁssion, pf,n ¼
2pf0dn,A/2, whereas for the physiological ﬁssion, pf,n ¼
2pf0/(A  1). The instantaneous ﬁssion assumption
requires pf;0  p; p9: In what follows, for the two-
dimensional case we ﬁx p ¼ 2p9, corresponding to an
initial seed of size 10 for which there are two locations to
attach a dimer. For large A, these results are insensitive to
the choice of p9.
We can identify the doubling time from Eqs. 12 and 13 by
the following procedure: ﬁrst, Laplace transform the set of
coupled equations to obtain a matrix equation in transform
space, then identify the largest real and positive eigenvalue
of the Laplace matrix. In all cases, we ﬁnd but one real and
positive eigenvalue. We have systematically varied the
ﬁssion size A and studied the dependence of the exponential
growth rate upon ﬁssion time. For ﬁbrils, the mean time to
aggregate to size A is tm  A/p, while for the two-
dimensional aggregates, the mean aggregation time goes as
tm  ln(A)/p9. In the one-dimensional case, we ﬁnd that for
large A $ 10, the doubling time t2 tends to 0.5(0.43)tm for
mechanical(physiological) ﬁssion. Hence, there is but
a factor-of-two difference between the aggregation time
and the doubling time. Since the numerical difference
between mechanical and physiological ﬁssion is not sub-
stantial, we have examined only the mechanical ﬁssion
model for the two-dimensional aggregate. In this case, for
large A $ 20, we ﬁnd that the largest eigenvalue of the
Laplace matrix goes as ’ 0:4=p9 independent of A, whereas
FIGURE 3 Ratio of characteristic dou-
bling time (t2) to mean incubation time (tm)
as a function of ﬁssioning size A for single
seed growth in two dimensions for different
monomer concentrations, showing asymp-
totic compression as c ! 0.
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the aggregation time-scales as ln(A)/p9. Hence, for sufﬁ-
ciently large A it is possible to make t2=tm  1:
These results have the attractive feature of linking the
aggregation time, which we associate with the lag phase, to
the doubling time in ﬁssion. In the one-dimensional case, so
long as the ﬁssion is binary (two fragments), the roughly
factor-of-two difference in tm and t2 is very difﬁcult to avoid.
However, for the two-dimensional case, it is possible to have
a jagged boundary arise after binary ﬁssion which allows
more rapid aggregation to A from A/2, so that t2 calculated
in the previous paragraph is an upper bound for mechanical
ﬁssion.
However, we acknowledge that other processes may be
responsible for the ﬁssion. In particular, we cannot rule out
continuous ﬁssioning of fragments off of large aggregates
which may lead to a very different result provided the ﬁssion
rate is comparable to growth rates.
DOSE-INCUBATION CURVE
In this section, we will look at the total incubation time and
how it varies as a function of the inoculated dose using the
aggregation-time distributions derived in the previous
sections, and explore the extent to which it provides
a quantitative description of experimental dose-incubation
curves. As discussed before, a key advantage of the two-
dimensional growth models is that, with a suitable ﬁssioning
scenario, they lead to lag times much larger than doubling
times. This is difﬁcult to accomplish with the one-dimen-
sional growth models. However, in this section we will
assume that the doubling time is an independent free
parameter. This allows us to ﬁt the experimental dose-
incubation curves by both one- and two-dimensional models.
The constraints on relative values of lag times and doubling
times will be brought up in our discussions in the next section.
We now proceed to calculate the incubation time as
a function of inoculated dose within our model for both one-
and two-dimensional aggregation models and compare with
laboratory data. Consider ﬁrst the DIC of the 263K hamster
scrapie strain. Kimberlin and Walker (1986) have de-
termined the DIC along with independent measurements of
the doubling time t2 and the ﬁnal infectivity for this strain.
The doubling time t2 can also be inferred from the DIC in the
region where it shows a logarithmic dose dependence.
Besides this experimental data, we need to know the
clearance ratio ri which gives the percentage of the number
of infectious seeds in a given inoculum which are removed
by rapid initial clearance. Let us illustrate this for the case of
1 LD50 unit: in our model this corresponds to having a 50%
probability of attaching a single infectious seed. Corre-
spondingly, the initial inoculum has to contain, on average,
50=ð100 riÞ seeds (for ri [ 50%, typical values from
experiment are ri ; 99%; Manuelidis and Fritch, 1996). We
treat ri as a parameter in our model to be determined by
ﬁtting the DIC. Using this, in conjunction with our results for
the aggregation time distributions, we can generate theoret-
ical DICs using the method outlined in A Model Distribution
and Dose-Incubation Curves.
For a ﬁxed aggregation size A, with probability of
attachment p and infectivity ratio ri (which are the pa-
rameters we use to ﬁt the DIC), we then calculate the mean-
square deviation (S2) (normalized by the experimental error
estimates for each data point) between the theoretical and
experimental DICs. Minimizing S2 gives us the optimal
parameters, p and A, for the particular strain for a given
value of ri within our model.
We consider ﬁrst the DIC for the 263K hamster scrapie
strain. In carrying out the ﬁtting, we have ignored the results
at the highest doses since in this limit we are approaching the
saturation of the incubation time. Thus the data which we are
ﬁtting consists of ﬁve data points corresponding to ﬁve serial
10-fold dilutions. For our two-dimensional growth model,
we get a good ﬁt to the experimental data as indicated in Fig.
4 top. The optimal parameters in this case are A ¼ 16 (with
Ai ¼ 10), p ¼ 0.025 day1 and ri ¼ 0 (which seems
unphysical) for which S2 ; 0.07. For a more realistic value
of ri; 88%, we getA¼ 16, p¼ 0.16 day1 with S2; 1.14.
From the ﬁtting, one can see that the clearance ratio ri cannot
be much greater than ri ; 88% due to the constraints
imposed by the experimental incubation and doubling times.
It should be noted, furthermore, that the above procedure
does not uniquely determine these parameters since
comparably good ﬁts are obtained for higher values of A
by correspondingly adjusting p. For the one-dimensional
growth model, we also get a good ﬁt with S2; 0.35 for A ¼
8 (with Ai ¼ 4) and p ¼ 0.11 day1.
One of the unusual features of the 263K scrapie strain in
hamsters is that at high doses the lag time is negligibly small.
This feature is clearly seen in the time-course measurements
(Kimberlin and Walker, 1986) of infectivity and also accords
with the theoretical best-ﬁt results described above. To test
our procedure for what is arguably a more representative
strain, we have also obtained a ﬁt for the experimental DIC
for the ME7 strain in C57BL mice (Taylor et al., 2000). This
data effectively corresponds to mean incubation times for
four serial 10-fold dilutions, ignoring the incubation times at
the highest dose which correspond to saturation of the DIC.
The results obtained by using our two-dimensional growth
model are shown in Fig. 4middle. In this case, the theoretical
ﬁt is not as good as that obtained for the 263K strain; the
optimal parameters correspond toA¼ 140, p¼ 0.033 day1
for ri ¼ 99 which gives S2 ; 3.75. A comparably good ﬁt
was obtained by using the one-dimensional growth model
with the optimal parametersA¼ 40, p¼ 0.23 day1 for ri¼
99, which gave S2 ; 5.02. However, in contrast with the
263K strain, the theoretical results for the ME7 strain give
rise to a signiﬁcant lag time of;50 days for the highest dose
inoculated. This is a testable prediction for time-course
measurements of infectivity for the Me7 strain in C57BL
mice.
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Finally, we have used the above procedure to analyze the
Sc237 scrapie strain in hamsters. In many respects, this strain
is similar to the 263K scrapie strain in hamsters; however, an
analysis of the respective DICs reveals some signiﬁcant
differences. Based on the best-ﬁt formula for the DIC
(Prusiner et al., 1999), we can estimate a doubling time t2 for
the Sc237 strain to be ;2.1 days whereas the doubling time
for the 263K strain is ;3.9 days. This difference is also
reﬂected in our theoretical best-ﬁt DIC curve for this strain
which, for ri ¼ 99, is given by the parameters A ¼ 80, p ¼
0.052 day1. Note that the experimental data in this case was
obtained from the best-ﬁt formula for the DIC (Prusiner et al.,
1999) mentioned above. For our one-dimensional model, the
corresponding values are A ¼ 62, p ¼ 0.35 day1. Note that
the experimental data in this case was obtained from the best-
ﬁt formula for the DIC (Prusiner et al., 1999). Furthermore,
the experimental error estimates were not available for dose-
incubation data for this strain, so we assumed them to be the
same as that for the 263K strain in determining the best ﬁt.
Using the above ﬁts, we see that the theoretical prediction for
the mean lag time for an inoculated dose of 1 LD50 unit is
;50 days. This value seems to be in good agreement with
the experimental results for low dose inoculations for this
strain (Prusiner et al., 1999).
The key results from our ﬁtting (using the two-di-
mensional growth model) are summarized in Table 1. Based
on the above results, we conclude that while our model
accounts for the features of the DIC and gives a good ﬁt to
the experimental data, the latter cannot be used to distinguish
between the one-dimensional and two-dimensional growth
morphologies or to ascertain the model parameters conclu-
sively. However, despite the ambiguity in the model pa-
rameters, there are some robust predictions we can make
after ﬁtting the DICs. We ﬁnd that the experimental DIC, in
conjunction with our model, can be used to make predictions
for the time course of infectivity: in particular we can predict
the lag-time as a function of dose. Although the duration of
the lag time that we calculate does depend on the clearance
ratio ri, we note that the trend is that increasing ri reduces the
lag time. Thus by measuring the lag time at high doses we
can determine the parameter ri in our model, which then
FIGURE 4 (Top) Experimental and theoreti-
cal dose-incubation curves for the 263K
hamster scrapie strain for ri ¼ 0. The x-axis
shows the incubation time and the y-axis shows
the logarithm of the number of seeds inocu-
lated. The theoretical curve is the best ﬁt to the
experimental data using the two-dimensional
growth model for aggregation. (Middle) Same
as A but for the Sc237 strain in hamsters with
ri ¼ 88. (Bottom) Same as A, but for the Me7
strain in C57BL mice with ri ¼ 88.
TABLE 1 Calculated best-ﬁt parameters and predictions for
low dose lag times for three scrapie strains
Strain t2 (days) ri Lag time (days) p9 (days
1) A S2
263K 3.9* 0 27.7 0.025 16 0.07
88 4.3 0.16 16 1.14
Sc237 2.1y 88 56.9 0.052 140 0.11
99 48.9 0.052 80 0.11
Me7 4.5z 88 107 0.033 360 3.86
99 89.6 0.033 140 3.75
*Kimberlin and Walker (1986).
yPrusiner et al. (1999).
zTaylor et al. (2000).
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yields testable predictions for the lag time at low doses. In
the case of the Sc237 scrapie strain in hamsters, our cal-
culated lag time at low dose agrees well with experimental
results for the same. For the other strains, the predictions for
the lag time at low dose are a key testable prediction of our
model.
CONNECTION TO EPIDEMIOLOGICAL DATA
We have found no dose-incubation time data available for
large mammals in the literature, so to gain insight we have
analyzed epidemiological data for BSE in cattle (Anderson
et al., 1996; Ferguson et al., 1998). In brief, our assumptions
and methods are as follows.
Model distribution
We apply only the two-dimensional model in the dilute dose
limit (suitable for digested prions); comparable quality ﬁts
can be obtained from the one-dimensional model, but
the estimated t2/tm ratio consistently and strongly violates
our mechanistic model result from Aggregate Fissioning,
whereas the bound for the two-dimensional case is satisﬁed.
Number of doublings
For mice and hamsters, with 1-g brains, 30 doublings to
incubation is typical (in the low dose limit). Given that the
mean cattle brain is 500 g, ;29 times that of mice/hamsters,
we take n2 ¼ 40 doublings from infection to incubation for
cattle.
BSE ﬁts
Anderson et al. (1996) provide a candidate incubation time
distribution which best ﬁts the epidemic time course, and
yields a mean incubation time ti ¼ 5 years and standard
deviation of 1.3 years. Let us introduce a parameter l ¼ 1 1
p/p9, which parameterizes the number of ways to attach to
the initial seed aggregate (e.g., forAi¼ 10 as in the previous
section, l¼ 3). Let n be the number of dimers added to reach
size A characteristic of ﬁssioning. We consider variation
with n, l here to assess the robustness of our conclusions. The
BSE distribution width ﬁxes p9 uniquely for given n, l, with
p9 weakly dependent upon n. We readily calculate the mean
ﬁrst arrival time tm(n, l, p9) (c(n1 l) c(l))/p9(c(x)¼ d ln
G(x)/dx is the digamma function), and, as per the discussion
in A Model Distribution and Dose-Incubation Curves, we
take the difference ti–tm to be n2t2, the length of the
exponential growth phase. We assume that a minimum t2
value for cattle is the 5 days typical for hamsters and mice
(see Table 2). From this, we can ﬁnd the maximum n value
for a given l. By assuming a maximum n-value for small
aggregates (plausibly taken as n ¼ 6), we generate an upper
bound for t2 of 15 days. The results for l ¼ 2,10 are
summarized in Table 2. Importantly, we ﬁnd the maximum
aggregate size at ﬁssion to be of order 80–100 monomers,
approximately independent of l for 2 # l # 10.
This analysis demonstrates only that the inferred in-
cubation time distribution, for which the width is ;30% of
the mean, is compatible with our hypothesis in the low dose
limit, and does not rule out variance from other mechanisms.
The low dose limit is reasonable for food-based infection.
However, other sources of variance may arise, in this limit,
from variation in dose, brain and body size, transportation
of infection inside the body, etc., and should also be
investigated.
An interesting conclusion from the analysis of the BSE
data especially is that the doubling times found within our
model are quite comparable to those from small animal
studies, so that the order-of-magnitude variation in in-
cubation time must be ascribed to slower attachment rates.
The strongest control of that for our model is concentration.
Given the potential role of prion proteins in limiting
oxidative damage of synapses (Guentchev et al., 2002),
and the slower metabolic rate of large mammals, it would
appear that metabolic regulation of normal prion monomer
concentration is an intriguing possibility for further explo-
ration.
DISCUSSION
Recall that our basic hypothesis is that incubation times are
controlled by prion aggregation around infectious external
seeds on the neuronal surface. Furthermore, in our cal-
culations, the distribution of aggregation times arises from
the stochastic growth process from seeds of a given initial
size. That only a narrow range of seed sizes is relevant here
may be motivated by size sensitivity of the blood-brain
barrier, the attachment probability, and the transportability of
the seeds. Our basic assumption is that the lag phase
corresponds to growth from initial seeds to a characteristic
ﬁssioning dimensionA, after which one gets a multiplication
in seeding centers and an exponential growth in infectivity.
That there is a long lag time despite external seeding by
intracerebral inoculation (Manuelidis and Fritch, 1996;
Kimberlin and Walker, 1988), and a doubling time which
is typically signiﬁcantly shorter (Manuelidis and Fritch,
1996), both of which become sharply deﬁned at high doses,
seems to be a general feature of the prion diseases. Our two-
dimensional compact aggregate model, with the assumptions
of the preceding paragraph, explains these facts. In par-
TABLE 2 Fits to incubation time distribution for BSE
l n p9 (yrs1) tm (yrs.) t2 (days)
2 6 0.57 2.8 20
2 23 0.61 4.5 5
10 6 0.15 3.2 16
See Ferguson et al. (1998).
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ticular, two-dimensional compact aggregation generates
a broad distribution of aggregation times for a single seed
with a well deﬁned sharp onset time (t0) and mean ag-
gregation time (tm). With increasing number of seeds (Di),
the distribution of times for the ﬁrst seed to reach the typical
ﬁssioning size A will narrow. Correspondingly the lag time,
determined by the ﬁrst ﬁssioning event, will become sharply
deﬁned and concentrate at the onset time, which only weakly
depends upon Di.
The doubling time (t2) is deﬁned by ﬁssioning and
subsequent growth from size A/2 to A. Since growth from
different seeds is independent, self-averaging gives a sharply
deﬁned t2. Thus at high doses both the lag time and doubling
time are sharply deﬁned, which accounts for one of the most
striking features of prion diseases: the reproducibility of
incubation times at high doses. Indeed, we can explain
several features of the dose-incubation curve. Notably, above
a saturation dose Ds, the incubation time does not decrease,
whereas for D\ Ds, the incubation time varies as log(D),
showing deviations from the log only below a much smaller
value Dmin (Prusiner et al., 1982; Masel et al., 1999). The
total incubation time is the sum of the lag time and ndt2,
where nd is the number of doubling steps. Assuming that the
onset of clinical symptoms is related to the damage of a ﬁxed
number of neurons (Nowak et al., 1998), the logarithmic
dose dependence of the number of doubling steps follows
from the fact that number of seeds grows exponentially in the
ﬁssioning stage. In the range Dmin\ D\ Ds, the lag time
does not change appreciably with dose, thereby giving rise to
the logarithmic dose dependence of the incubation time in
this range. At low doses (D\Dmin), the lag time increases
toward tm1 (the mean aggregation time for a single seed)
giving rise to a broad distribution of incubation times and the
deviation from the logarithmic behavior in the DIC which is
observed experimentally. (Prusiner et al., 1980)
Furthermore, we note that in our mechanistic ﬁssioning
model, the doubling time (t2) is bounded above by the time to
grow from size A/2 to A. If the ﬁssion produces jagged
fragments, these can be effectively ﬁlled by monomers
which will accelerate the subsequent growth process. This is
only possible for two-dimensional compact aggregates and
not for one-dimensional ﬁbrils, for which the exposed ends
will always be limited to dimer growth. This possibility may
account for the effective 1/c dependence in the incubation
time observed for transgenic mice with multiple copies of the
hamster prion protein gene (Prusiner et al., 1990), noting that
for hamsters the doubling phase appears to dominate
incubation (Kimberlin and Walker, 1986).
A key difference between the one-dimensional and two-
dimensional morphology (shown in Stochastic Analysis of
Aggregation) is that, within our model, in case of the latter,
i), the lag time can be an order-of-magnitude larger than the
doubling time. If the total time in doubling steps becomes
large compared to the lag time, the overall distribution will
be relatively narrow. Thus, only in the case of two-
dimensional growth can one get ii), a wide distribution for
the overall incubation time, with a width comparable to the
mean. Thus assuming i) and ii) to result entirely from the
growth processes discussed here strongly points to a two-
dimensional (or three-dimensional) morphology as control-
ling the incubation times. It is encouraging to note that recent
experiments (Wille et al., 2002) have found the ﬁrst ex-
perimental evidence of hexagonally coordinated two-dimen-
sional prion aggregates.
The early growth morphology clearly deserves further
experimental attention (Horiuchi and Caughey, 1999;
Rochet and Lansbury, 2000). Typically, the in vitro morph-
ology of prion aggregates has been found to be ﬁbrillar
(Ionescu-Zanetti et al., 1999). Frequently large ﬁbrillar
aggregates are also observed post mortem in brain tissues.
The morphology and size scale for aggregates that cause
neuronal death and infection is not known. One could argue
that the reason why in vitro aggregates are not infectious is
because they do not have the proper morphology. We
speculate that the attachment to lipid membranes could make
a vital difference to the aggregation process, which is
missing in the in vitro experiments. It would be very interest-
ing to carry out the in vitro studies of prion aggregation in
presence of lipid membranes.
An important byproduct of our analysis is the ability to
predict the time course of infectivity from the DIC. Provided
we take the doubling time (td) as an independent experi-
mental parameter, such predictions are very robust and do
not rely on many details of the aggregation-ﬁssioning model,
including initial growth morphologies. Such predictions are
particularly signiﬁcant since experiments which measure the
time course of infectivity, and hence determine the lag phase,
are extremely expensive and time-consuming. This dose
dependence of the lag phase may well be a signiﬁcant factor
in assessing the risk of infection.
Our results indicate that we can infer the (average) time
course of infectivity using the information supplied by the
experimental DIC. Thus, based on our ﬁts to the experi-
mental DIC, we have made testable predictions for the time
course of infectivity, and in particular the lag time, as
a function of dose. These predictions are in good agreement
with the existing experimental results and their further
experimental validation would prove very useful.
A factor which signiﬁcantly affects the lag time is the
probability of dimer attachment p; lowering p increases the
lag time. This is relevant in understanding the species barrier
effect in which there is a reduction of incubation times with
multiple passages in interspecies infection (Lasme´zas et al.,
1997). During ﬁrst passage, the attachment of dimers is
initially nonhomologous but as the seed size increases it
should change to homologous attachment. Since the non-
homologous attachment probability should be smaller
(Horiuchi et al., 2000), the lag phase should be longer for
ﬁrst passage as compared to subsequent passages. Thus, in
our picture, most of the difference in incubation times should
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come from the lag phase and the exponential growth phase
should be similar between ﬁrst and second passages. This has
been observed experimentally for hamster scrapie passaged
in mice (Kimberlin and Walker, 1978). We note that the
estimated dimer attachment rates for mice and hamsters
range from 9–60 per year (compare with Table 1), whereas
for cattle they are maximally 0.6 per year.
Furthermore, we observe that the estimated aggregate
sizes are comparable between large animals (cattle) and
small animals, all in the ballpark of tens of nm, which is
precisely the estimated size of the lipid rafts on which prions
are hypothesized to rest (Simons and Toomre, 2000). The
comparable sizes of aggregates at ﬁssion we ﬁnd in our
model between small and large mammals strongly suggests
that the primary determinant of the lag time is the dimer
attachment rate which is regulated primarily by the
concentration (for a given strain) within our model. This
leads us to speculate that the concentration of normal prion
proteins must vary dramatically between large and small
species, which naturally leads us to envision a link to
metabolic rate. Such a link is plausible if prion proteins play
a functional role in relieving oxidative stress as has been
proposed elsewhere (Guentchev et al., 2002). It would be of
interest to experimentally test this hypothesis of enhanced
homeostatic PrPc concentration in small animals relative to
large ones.
In summary, we have explored the statistics of the two
phases corresponding to growth of infectivity after in-
tracerebral inoculation. We associate the lag phase with
growth of prion aggregates up to a ﬁssioning dimension and
explore the consequences of aggregate morphology on
incubation time distributions using cellular automata-based
models. Our analysis accounts for the striking reproducibil-
ity of incubation times at high doses and predicts that the
broadening at low doses should be accompanied by increases
in the mean lag-phase time. Furthermore, we have presented
a general scheme for inferring the dose-incubation curve
given the distribution of lag-phase times for individual seeds
and the infectivity doubling time. Using the calculated lag-
phase distributions for our one-dimensional and two-di-
mensional growth models, we used this scheme to provide
theoretical ﬁts to experimental DICs based on which we
make predictions for the time course of infectivity. Finally,
we considered the epidemiological data for BSE and showed
that, within our model, the aggregate size for BSE is
comparable to that for scrapie in smaller animals such as
hamsters and mice.
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